Malin Corporation | MLC - Loan Capital



Malin Corporation reported EUR0 in Loan Capital for its fiscal semester ending in December of 2024.


Loan Capital Change Date
Alaunos Therapeutics USD 0 0 Dec/2024
ALKERMES USD 0 0 Mar/2025
Avita Medical AUD 42.24M 1.25M Dec/2024
Dianthus Therapeutics USD 0 0 Dec/2024
Eurofins Scientific SE EUR 3.58B 443.8M Jun/2025
Ionis Pharmaceuticals USD 625.49M 625.22M Jun/2025
IQVIA Holdings USD 14.18B 1.07B Jun/2025
Lonza CHF 4.24B 602M Dec/2024
Malin Corporation EUR 0 0 Dec/2024
Moderna USD 32M 3M Jun/2025
Organon & Co USD 8.9B 36M Jun/2025
Revvity USD 3.21B 45.94M Jun/2025
Tectonic Therapeutic USD 186K 201K Jun/2025
Viatris USD 12.79B 1.39B Jun/2025
Xeris Pharmaceuticals USD 218.63M 1.62M Jun/2025